the U.S. Food and Drug Administration

ASCRS To Participate In and Co-Fund Study on Post-LASIK Quality of Life with U.S. Food and Drug Administration Business Wire via Yahoo! Finance Mon, 07 Apr 2008 8:36 AM PDT CHICAGO----The American Society of Cataract and Refractive Surgery today announced that it will participate in a post-LASIK quality of life study with the Joint LASIK Study Task Force, which includes the U.S. Harry and David recall espresso beans UPI Mon, 07 Apr 2008 7:49 AM PDT The U.S. Food and Drug Administration announced the recall of approximately 66,500 bags of Harry and David-brand espresso beans due to a labeling error. Harry and David recall espresso beans Moldova.org Mon, 07 Apr 2008 8:03 AM PDT The U.S. Food and Drug Administration announced the recall of approximately 66,500 bags of Harry and David-brand espresso beans due to a labeling error.The FDA said Harry and David Inc. of Medford, Ore., voluntarily recalled the bags of chocolate covered select blend espresso beans because they might contain milk not declared on the ingredient statement, posing a health hazard for people ... ASCRS to participate in and co-fund study on post-lasik quality of life with US FDA EurekAlert! Mon, 07 Apr 2008 8:54 AM PDT CHICAGO, ASCRS Symposium and Congress, (April 7, 2008) – The American Society of Cataract and Refractive Surgery (ASCRS) today announced that it will participate in a post-LASIK quality of life study with the Joint LASIK Study Task Force, which includes the U.S. Food and Drug Administration (FDA), the National Eye Institute (NEI), ASCRS and the American Academy of Ophthalmology. LG Sciences brand supplements seized Moldova.org Mon, 07 Apr 2008 9:31 AM PDT More than $1.3 million worth of dietary supplements have been seized from LG Sciences LLC of Brighton, Mich., because they violate federal law, officials said.The U.S. Food and Drug Administration said it asked U.S. marshals to seize the products because they contain unapproved food additives or new dietary ingredients.The dietary supplements seized were marketed and distributed online and in ... Federal Agents Seize Nearly 1.3 Million Dollars Of Illegal Dietary Supplements Medical News Today Mon, 07 Apr 2008 5:04 AM PDT At the request of the U.S. Food and Drug Administration, on Wednesday U.S. Marshals seized more than $1,301,712 of dietary supplements from LG Sciences, LLC, of Brighton, Mich., because the products contain unapproved food additives and/or new dietary ingredients that cause the products to violate the law. Labeled as dietary supplements, the products are marketed for use by body builders. FDA Approves ROTARIX(R) Rotavirus Vaccine Medical News Today Mon, 07 Apr 2008 4:19 AM PDT AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced that its partner, GlaxoSmithKline (GSK), has received approval from the U.S. Food and Drug Administration (FDA) for ROTARIX® for the prevention of rotavirus gastroenteritis in infants. With only two doses, ROTARIX will offer protection against the most commonly circulating rotavirus types in the U.S. Taro receives tentative US FDA nod for lamotrigine tablets PharmaBiz Mon, 07 Apr 2008 1:40 AM PDT Taro Pharmaceutical Industries Ltd. has received tentative approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lamotrigine tablets 25 mg, 100 mg, 150 mg, and 200 mg (Lamotrigine tablets). TYPE 2 DIABETIC PATIENTS NEEDED The Buffalo News Mon, 07 Apr 2008 3:47 AM PDT The Diabetes-Endocrinology Center of WNY at Millard Fillmore Hospital under the direction of Dr. Paresh Dandona is conducting a new research study for Type 2 diabetic patients with a new medication. This is an investigational medication that is not yet approved by the Food and Drug Administration (FDA). This medication is being used in combination with metformin (also known as Glucophage). Taro Receives Tentative FDA Approval For Lamotrigine Tablets ANDA Medical News Today Mon, 07 Apr 2008 4:19 AM PDT Taro Pharmaceutical Industries Ltd. ("Taro," the "Company," Pink Sheets: TAROF) reported today that it has received tentative approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Lamotrigine Tablets 25 mg, 100 mg, 150 mg, and 200 mg ("Lamotrigine Tablets").

See more news stories that match my keyword